ClinicalTrials.gg
RecruitingNCT07422441CLOSE-STATUpdated Oct 7, 2026

Compliance-Guided Abdominal Wall Closure Strategy in Large Ventral Hernia Repair

An interventional study of Compliance-Guided Abdominal Wall Closure Decision Strategy in Hernia, Ventral, Hernia Incisional and Postoperative Complications, sponsored by Swissmed Hospital. Recruiting at 1 site in Poland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-07.

Sponsored by Swissmed Hospital · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Feb 2026; still recruiting 8 months later.
Updated Oct 7, 2026Now RecruitingFirst site in Poland+2 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

People undergoing repair of large ventral hernias can develop breathing problems after surgery, especially around the time when the abdominal wall is closed. During closure, pressure inside the abdomen may increase and lung mechanics can worsen. This study will evaluate a structured intraoperative decision approach that uses standard anesthesia measurements of static respiratory system compliance at predefined timepoints to support the choice of abdominal wall closure technique. The main goal is to assess the rate of early postoperative respiratory failure within 72 hours after surgery.

Read the detailed description

This is a prospective, single-arm, decision-guided interventional study in adults undergoing elective repair of large ventral hernias after preoperative botulinum toxin A preparation as part of the local prehabilitation pathway. The study focuses on the intraoperative abdominal wall closure phase, when physiological changes may increase the risk of early postoperative respiratory complications.

Mechanical ventilation is standardized during measurement timepoints using volume-controlled ventilation with tidal volume set to 6 mL per kg of ideal body weight and a positive end-expiratory pressure of 10 cmH2O. Full neuromuscular blockade is ensured to minimize measurement variability. Static respiratory system compliance is recorded at three predefined timepoints: after endotracheal intubation before skin incision (baseline), during abdominal wall closure (decision timepoint), and before extubation. The intraoperative decision strategy considers a closure physiologically tolerable when static compliance remains at least 70 percent of the baseline value. If compliance falls below this threshold at the closure decision timepoint, the surgical team considers avoiding tension closure and may use a bridging or alternative closure approach according to clinical judgment. When intra-abdominal pressure is measured as part of routine care, these values are recorded as an additional physiological parameter.

Perioperative data are captured in a dedicated case report form, and patients are observed for early respiratory outcomes during the first 72 hours after surgery.

02

Conditions studied

  • Hernia, Ventral
  • Hernia Incisional
  • Postoperative Complications
  • Respiratory Insufficiency

Keywords

  • adbominal wall closure
  • static compliance
  • respiratory system compliance
  • intraoperative monitoring
  • intra-abdominal pressure
  • complex hernia repair
  • botulinum toxin a
03

In context

Hernia, Ventral

230 studies on the registry are indexed under Hernia, Ventral; 45 are open to participants now.

This study's planned enrollment of 50 is below the median of 90 across 153 interventional studies indexed under Hernia, Ventral.

Browse Hernia, Ventral studies →

Lead sponsor

Swissmed Hospital is the lead sponsor of 8 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older
  • Elective repair of a large ventral abdominal wall hernia (including incisional hernia)
  • Preoperative botulinum toxin A preparation performed as part of the local prehabilitation pathway
  • Preoperative abdominal CT available
  • General anesthesia with mechanical ventilation and feasibility of standardized intraoperative respiratory mechanics measurements

Exclusion criteria

Exclusion Criteria:

  • Severe preoperative respiratory failure judged to preclude standardized intraoperative respiratory mechanics assessment
  • Inability to obtain reliable static respiratory system compliance measurements at predefined timepoints
  • Hemodynamic instability preventing protocolized measurements (as judged by the anesthesiologist)
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Compliance-Guided Closure Strategy

    Participants undergo elective large ventral hernia repair after preoperative botulinum toxin A preparation. During surgery, a predefined intraoperative decision strategy is applied during abdominal wall closure using standardized measurements of static respiratory system compliance (Cstat) at predefined timepoints (baseline after intubation before incision, during closure as the decision point, and before extubation). Standardized ventilation settings are used during measurements (volume-controlled ventilation, tidal volume 6 mL/kg ideal body weight, PEEP 10 cmH2O) with full neuromuscular blockade. A closure is considered physiologically tolerable when Cstat remains at least 70 percent of baseline; if Cstat decreases below this threshold during closure, the surgical team considers avoiding tension closure and may use a bridging or alternative closure approach according to clinical judgment. When intra-abdominal pressure is measured as part of routine care, values are recorded.

    Other: Compliance-Guided Abdominal Wall Closure Decision Strategy

Interventions

  • OtherCompliance-Guided Abdominal Wall Closure Decision Strategy

    A predefined intraoperative decision strategy that uses standardized measurements of static respiratory system compliance (Cstat) during abdominal wall closure to support selection of closure technique, with a predefined physiological tolerance threshold based on the baseline measurement.

    Also known as: Static Compliance-Guided Closure Algorithm, Cstat-Guided Closure Strategy, Physiology-Guided Abdominal Wall Closure

06

What researchers measure

Primary outcomes

  1. Incidence of postoperative respiratory failure within 72 hours

    Percentage of participants who develop postoperative respiratory failure within 72 hours after surgery, defined as meeting ≥1 of the following criteria: * Reintubation for respiratory reasons; OR * Non-invasive ventilation (NIV) or high-flow nasal oxygen (HFNO) delivered for \>6 consecutive hours for respiratory reasons; OR * Escalation of respiratory support for respiratory reasons (e.g., increase in oxygen delivery device/flow/FiO₂ or ventilatory support level). Unit of measure / tool: % of participants (derived from routine clinical documentation: anesthesia record, PACU/ICU charts, respiratory therapy notes).

    Time frame: Within 72 hours after surgery

Secondary outcomes

  1. Change in static respiratory system compliance from baseline to closure decision

    Change in static respiratory system compliance (Cstat) from: * Baseline: after intubation, before incision to * Closure decision timepoint: immediately prior to the final abdominal wall closure strategy decision under standardized ventilation conditions. Unit of measure / tool: ΔCstat (mL/cmH₂O) measured/calculated from the mechanical ventilator using: * Cstat = VT / (Pplat - PEEP) (if you intend this exact formula, include it) * VT, Pplat, PEEP obtained from ventilator readings (anesthesia machine record)

    Time frame: Intraoperative (baseline to closure decision timepoint)

  2. Proportion of cases requiring change in abdominal wall closure strategy

    Percentage of participants in whom the preoperatively planned tension closure is changed at the closure decision timepoint to: * bridging, or * another predefined alternative closure approach based on intraoperative physiological assessment per protocol. Unit of measure / tool: % of participants (surgeon operative report + intraoperative record; categorized closure strategy).

    Time frame: Intraoperative (during abdominal wall closure)

  3. Intra-abdominal pressure during abdominal wall closure

    Intra-abdominal pressure (IAP) values recorded per routine care at prespecified intraoperative timepoints (as applicable in your workflow). If you want one summary statistic, specify it (recommended), e.g.: * Peak intraoperative IAP during closure, or * IAP at closure decision timepoint Unit of measure / tool: mmHg, measured using the site's routine IAP technique (e.g., bladder pressure via urinary catheter system) as documented in the anesthesia/ICU record.

    Time frame: Intraoperative (at time of measurement)

07

Study locations

1 of 1 sites recruiting
  • LUX MED Hospital, Gdańsk
    Gdansk, 80-215, Poland
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2026 (actual). Primary completion is estimated for Nov 2026, 8 months after the start.

Of 75 non-industry interventional studies with no phase under Hernia, Ventral, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 48. This study's planned 8 months is below that.

Counting every sponsor, half of 88 studies reached it within 37 months; a quarter within 19 and three quarters within 56.

Primary completion moved once since we started tracking on Sep 25, 2026: Aug 2026 → Nov 2026, on Oct 7, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 5, 2026
First posted
Feb 20, 2026
StartActual
Feb 20, 2026
Primary completionEst.
Nov 1, 2026was Aug 2026
CompletionEst.
Nov 1, 2026
Last update
Oct 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 7, 2026
Sites
1 site added — first site in Poland
Show site
  • LUX MED Hospital, Gdańsk · Gdansk, Poland
Oct 7, 2026
Primary completion
Aug 1, 2026→Nov 1, 2026
Oct 7, 2026
Show all 1 update
  1. Oct 7, 2026
    Not yet recruiting→Recruiting
    1 site added — first site in Poland
    Show site
    • LUX MED Hospital, Gdańsk · Gdansk, Poland
    Primary completion Aug 1, 2026→Nov 1, 2026
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07422441
Lead sponsor
Swissmed Hospital
Responsible party
Sponsor
First posted
Feb 20, 2026
Start date
Feb 20, 2026
Primary completion
Nov 1, 2026 (estimated)
Completion
Nov 1, 2026 (estimated)
Last update
Oct 7, 2026

Study contacts

Magdalena Halska
Contact
worldofsurge@gmail.com
607870690
Irmina Anna Śmietański, MD, PhD
principal investigator · Śmietański Hernia Center, LUX MED Hospital in Gdańsk
Maciej Śmietański, Prof.
study chair · Śmietański Hernia Center, LUX MED Hospital in Gdańsk
Mateusz Zamkowski, MD, PhD
study director · Śmietański Hernia Center, LUX MED Hospital in Gdańsk

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion